gemcitabine has been researched along with arginyl-glycyl-aspartyl-serine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aasrum, M; Amrutkar, M; Gladhaug, IP; Verbeke, CS | 1 |
1 other study(ies) available for gemcitabine and arginyl-glycyl-aspartyl-serine
Article | Year |
---|---|
Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Survival; Coculture Techniques; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Extracellular Matrix; Fibronectins; Flavonoids; Gemcitabine; Humans; MAP Kinase Signaling System; Oligopeptides; Pancreatic Neoplasms; Pancreatic Stellate Cells; Phosphorylation; Proteome; Proto-Oncogene Proteins c-akt | 2019 |